Cultured stromal cells: An in vitro model of prostatic mesenchymal biology

Prostate

Volumn 45, Issue 2, 2000, Pages 115-123

  Peehl, Donna M ^a   Sellers, Robert G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; Cancer; Cell culture; Growth factors; Smooth muscle; Stroma

Indexed keywords

CELL MARKER; GROWTH FACTOR; HORMONE; PEPTIDE;

ARTICLE; CELL CULTURE; CELL TYPE; CYTOLOGY; GROWTH REGULATION; HORMONAL REGULATION; IN VITRO STUDY; MESENCHYME CELL; MUSCLE DEVELOPMENT; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SMOOTH MUSCLE; STROMA CELL;

ADENOCARCINOMA; ADRENERGIC AGONISTS; ANDROGENS; ANIMAL; BIOLOGICAL MARKERS; CELL CULTURE; CELL LINE; CELLS, CULTURED; EPITHELIAL CELLS; ESTROGENS; GROWTH SUBSTANCES; HUMAN; MALE; MESODERM; MODELS, BIOLOGICAL; PROSTATIC HYPERPLASIA; STROMAL CELLS; UROGENITAL SYSTEM;

EID: 0033819910     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20001001)45:2<115::AID-PROS5>3.0.CO;2-C     Document Type: Article

References (119)

1. Prostate stroma: Physiology
2. Prostatic ductal system in rats: Regional variation in stromal organization
3. A reliable system for the culture of human prostatic cells
4. Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts
5. Stromal cells of the human prostate: Initial isolation and characterization
6. Immunocytochemical characterization of explant cultures of human prostatic stromal cells
7. Androgen responsiveness of stromal cells of the human prostate: Regulation of cell proliferation and keratinocyte growth factor by androgen
8. Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate
9. Differences in growth requirements between epithelial and stromal cells derived from rat ventral prostate in serum-free primary culture
10. Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections
11. A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates
12. Cell lineage characteristics of human prostatic stromal cells cultured in vitro
13. Defined medium for normal adult human prostatic stromal cells
14. Androgen-regulated proliferation and gene transcription in a prostate smooth muscle cell line (PS-1)
15. Interaction between prostatic fibroblast and epithelial cells in culture: Role of androgen
16. Isolation and characterization of a novel human prostatic stromal cell culture: DuK50
17. A human prostatic stromal myofibroblast cell line WPMY-1: A model for stromal-epithelial interactions in prostatic neoplasia
18. Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma
19. The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment
20. Evidence of stem cells in the adult prostatic epithelium based upon responsiveness to mesenchymal inductors
21. Regional differences in the inductive activity of the mesenchyme of the embryonic mouse urogenital sinus
22. The influence of mesenchyme of neonatal seminal vesicle and embryonic urogenital sinus on the morphologic and functional cytodifferentiation of Dunning prostatic adenocarcinomas: Roles of growth factors and proto-oncogenes
23. Transforming growth factor beta 1 transduced mouse prostate reconstitutions: I. Induction of neuronal phenotypes
24. Tissue and cell-cell interactions in prostate cancer progression
25. Glucocorticoid regulation of transforming growth factor-beta activation in urogenital sinus mesenchymal cells
26. Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle
27. Normal development and carcinogenesis of the prostate. A unifying hypothesis
28. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta
29. Differential growth rates in stromal cultures of human prostate derived from patients of varying ages
30. Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers
31. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells
32. Basic FGF, EGF, and PDGF modify TGFbeta-induction of smooth muscle cell phenotype in human prostatic stromal cells
33. Benign prostatic stromal cells are regulated by basic fibroblast growth factor and transforming growth factor-beta 1
34. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and -beta 3 by cultured human prostate cells
35. Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta)
36. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells
37. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry
38. Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy
39. The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates
40. Hormonal regulation of the androgen receptor expression in human prostatic cells in culture
41. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: Oestrogen regulation of the androgen receptor
42. Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma
43. A novel coculture model for benign prostatic hyperplasia expressing both isoforms of 5 alpha-reductase
44. Platelet derived growth factor (PDGF), androgens and inflammation: Possible etiologic factors in the development of prostatic hyperplasia
45. Developmental and hormonal regulation of transforming growth factor-beta1 (TGFbeta1), -2, and -3 gene expression in isolated prostatic epithelial and stromal cells: Epidermal growth factor and TGFbeta interactions
46. Differential effects of vitamin D on normal human prostate epithelial and stromal cells in primary culture
47. Keratinocyte growth factor expression in hormone insensitive prostate cancer
48. Keratinocyte growth factor: An androgen-regulated mediator of stromal-epithelial interactions in the prostate
49. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor
50. Rapid induction of keratinocyte growth factor (FGF-7) and beta-actin after exposure of prostate stromal cells to androgen
51. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts
52. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin
53. Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate
54. Keratinocyte growth factor in the rat ventral prostate: Androgen-independent expression
55. Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates
56. Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate
57. Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration
58. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture
59. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts
60. Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: Demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellulardistribution
61. The localisation and expression of 5 alpha-reductase types I and II mRNAs in human hyperplastic prostate and in prostate primary cultures
62. Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin
63. Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease
64. Serenoa repens (Permixon): A 5alpha-reductase types I and II inhibitor - New evidence in a coculture model of BPH
65. Effects of a new 5 alpha reductase inhibitor (epristeride) on human prostate cell cultures
66. Peptide growth factors in the prostate as mediators of stromal epithelial interaction
67. Regulation of prostatic growth and function by peptide growth factors
68. Dysregulated expression of growth factors and their receptors in the development of prostate cancer
69. Intrinsic and extrinsic factors controlling benign prostatic growth
70. Cellular biology of prostatic growth factors
71. Basic fibroblast growth factor: A potential mediator of stromal growth in the human prostate
72. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells
73. Regulation of prostate growth by fibroblast growth factors
74. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate
75. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates
76. Amphiregulin is coordinately e pressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate
77. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods
78. Amphiregulin is expressed in primary cultures of prostate, myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue
79. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells
80. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells
81. Platelet-derived growth factor induces proliferation of hyperplastic human prostatic stromal cells
82. Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts
83. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells
84. The role of vitamin D in normal prostate growth and differentiation
85. Localization and expression of the alpha1A-1, alpha1B and alpha1D- adrenoceptors in hyperplastic and non-hyperplastic human prostate
86. Videoimaging of prostatic stromal-cell contraction: An in vitro model for studying drug effects
87. Influence of the alpha 1-adrenergic antagonist, doxazosin, on noradrenaline-induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells
88. Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist
89. The role of stromal-epithelial interaction in normal and malignant growth
90. Stromal-epithelial interactions in the normal and neoplastic prostate
91. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma
92. c-Met proto-oncogene expression in benign and malignant human prostate tissues
93. Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction
94. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro
95. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6
96. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
97. In vitro expression of endothelin-1 (ET-1) and the ETA and ETB ET receptors by the prostatic epithelium and stroma
98. Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts
99. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia
100. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease
101. Growth regulation of prostatic stromal cells by prostate-specific antigen
102. Establishment of a three-dimensional human prostate organoid coculture under microgravity-simulated conditions: Evaluation of androgen-induced growth and PSA expression
103. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
104. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates
105. Involvement of heparin affin regulatory peptide in human prostate cancer
106. Morphological analogies of fetal prostate stroma and stromal nodules in BPH
107. Pathology of benign prostatic hyperplasia. Insight into etiology
108. The IGF axis in the prostate
109. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture
110. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation
111. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia
112. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: Abnormalities in cells cultured from benign prostatic hyperplasia tissues
113. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues
114. Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic human prostates
115. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer
116. Abundant cysteine-rich protein-1 is localized in the stromal compartment of the human prostate
117. Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide
118. Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer
119. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia